Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 9091 AL 9105

The Christchurch point mutation in mouse APOE reduces Aβ-induced tau and α-synuclein pathologies

Soto-Faguás CM, O'Niel A, Mueller PA, Sanchez-Molina P, Woltjer RL, Raber J, Unni VK.

bioRxiv [Preprint]. 2025 Nov 7:2025.11.05.686857. doi: 10.1101/2025.11.05.686857.

Nuclear Alpha-Synuclein: Mechanisms and Implications for Synucleinopathies

Outeiro TF, Koss DJ.

Mov Disord. 2026 Mar;41(3):603-612. doi: 10.1002/mds.70138. Epub 2025 Nov 26.

Practices, Resources and Challenges in Parkinson's Disease Management in Asia: Movement Disorders in Asia Study Group Report

Mohamed Ibrahim N, Phuenpathom W, Jagota P, Bhidayasiri R, Pal PK, Lin CH, Kukkle PL, Hatano T, Lim SY, Myrzayev Z, Shang H, Ong JN, Rosales RL, Youn J, Aldaajani Z, Mittal SO, Nawi AM, Ugawa Y.

Mov Disord Clin Pract. 2026 Feb;13(2):379-392. doi: 10.1002/mdc3.70447. Epub 2025 Nov 26.

Deep Brain Stimulation: Mechanisms, Cost-Effectiveness, and Precision Applications Across Neurology and Psychiatry

Costin HP, Brehar FM, Corlatescu AD, Pruna VM.

Biomedicines. 2025 Nov 1;13(11):2691. doi: 10.3390/biomedicines13112691.

Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE-PD)

Dash D, Fabbri M, Saade J, van Munster M, Pedrosa D, Růžička E, Gal O, Ferreira JJ, Sánchez-Ferro Á, Lynch T, Eggers C, Singh A, Grimes D, Taljaard M, Rascol O, Mestre TA; and the iCARE‐PD consortium.

Mov Disord. 2026 Feb;41(2):445-454. doi: 10.1002/mds.70110. Epub 2025 Nov 27.

Neurological letter from Canada

Furtado S.

Pract Neurol. 2025 Nov 27:pn-2024-004473. doi: 10.1136/pn-2024-004473. Online ahead of print.

Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)

Rascol O, Ory-Magne F, Meissner WG, Maltête D, Defebvre L, Azulay JP, Thobois S, Houeto JL, Thalamas C, Sommet A, Geny C, Damier P, Anheim M, Marquès A, Viallet F, Giroud M, Lefaucheur R, Costentin G, Spampinato U, Samier-Foubert A, Carrière N, Mutez E, Mariani LL, Eusebio A, Prange S, Benatru I, Charif M, Brefel-Courbon C, Fabbri M, Galitzky M, Rousseau V, Saubion A, Catala H, Ferreira JJ, Burn DJ, Corvol JC; PREMANDYSK Study Group.

Mov Disord. 2026 Mar;41(3):729-740. doi: 10.1002/mds.70120. Epub 2025 Nov 29.

'What's in a Name?' Naming Genetically Determined Movement Disorders: Gap and Controversy

Marras C, Albanese A, Hallett M, Klein C, Lohmann K; Genetic Nomenclature in Movement Disorders Study Group Steering Committee; Jinnah HA.

Mov Disord. 2026 Feb;41(2):342-350. doi: 10.1002/mds.70143. Epub 2025 Nov 29.

Cerebrospinal Fluid Biomarkers of NLRP3 Pathway, Immune Dysregulation, and Neurodegeneration in Parkinson's Disease: A Meta-Analysis

Marinescu AM, Machado V, Pagano G, Muelhardt NM, Kustermann T, Mracsko EZ, Brockmann K, Shariati N, Anzures-Cabrera J, Zinnhardt B.

Mov Disord. 2026 Feb;41(2):466-477. doi: 10.1002/mds.70103. Epub 2025 Nov 29.

Effects of oral levodopa on motor symptoms and gait impairments in Parkinson's disease: a systematic review and meta-analysis

Lillebæk BS, Tran J, Dalgas U, Langeskov-Christensen M.

Expert Rev Neurother. 2025 Dec;25(12):1435-1449. doi: 10.1080/14737175.2025.2594999. Epub 2025 Nov 29.

Reduced distress tolerance and elevated depression in functional tremor: A comparative cross-sectional observational study of tremor disorders

Sheehan P, Deng Y, Phelps HE, Jasinski N, Pyle K, Coleman MM, Sblendorio D, Talkington D, Murray A, Memon AA, Moreno-Escobar MC, Frey J.

J Psychosom Res. 2026 Feb;201:112479. doi: 10.1016/j.jpsychores.2025.112479. Epub 2025 Nov 29.

Telerehabilitation for people with Parkinson's disease: protocol of a randomised clinical trial of mixed methods

Taveira RS, Vasconcellos LS, Bezerra CF, Aires DN, Dias de Oliveira AK, da Silva KOC, Melo LP, Ribeiro TS.

BMJ Open. 2025 Nov 29;15(11):e096285. doi: 10.1136/bmjopen-2024-096285.

Neuropalliative Care in Movement Disorders

Kluger BM.

Continuum (Minneap Minn). 2025 Dec;31(6):1637-1656. doi: 10.1212/cont.0000000000001640. Epub 2025 Dec 2.

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Reyes NGD, Di Luca DG, Marras C, Boot E, Yuen RKC, Lang AE, Bassett AS.

Mov Disord Clin Pract. 2025 Dec 3. doi: 10.1002/mdc3.70459. Online ahead of print.

Richardson Syndrome Variant of Progressive Supranuclear Palsy: A Case Report

Korucu I, Karakoyun Alpay T.

Cureus. 2025 Dec 2;17(12):e98307. doi: 10.7759/cureus.98307. eCollection 2025 Dec.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias